Andre C. Muller
-
Idorsia Therapeutics Poised to Cut Hundreds of Jobs in Restructuring
Idorsia Therapeutics is negotiating to sell global rights to its high blood pressure drug amid a restructuring that could eliminate up to 270 positions, writes…
-
Idorsia, U.S. Headquartered in Radnor, Aims for Asia Pacific Market
Swiss biopharmaceutical company Idorsia Ltd. has entered into negotiations to operate in the Asia Pacific region and gain licensing rights there for its products, writes…
Founding Partners
Advertisement
Affiliate Partners
Chamber Partners
